LOUISVILLE, Ky. / May 13, 2024 / Business Wire / Leading health insurer and health care services company Humana Inc. (NYSE: HUM) announced today that Jim Rechtin will assume the role of President and Chief Executive Officer effective July 1, 2024. As previously announced, Rechtin joined Humana as President and Chief Operating Officer in January as part of a long-planned CEO transition. Since then, he has worked in close partnership with...Read more
Reduces Operating Expense by over $5 million and Net Loss by over 50% compared to 2023 TAMPA, Fla., May 9, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced financial results for the first...Read more
Drove strong Q1 ‘24 results, focused on delivering coordinated, consumer-centric care to all populations through strong provider and payor partnerships and proactive consumer engagement Delivered Revenue of $245.1 million, Net Income from Continuing Operations of $5.7 million, Adjusted EBITDA of $2.5 million in Q1 ‘24, laying a solid foundation for continued profitable growth in 2024 NeueCare and NeueSolutions segments positioned for...Read more
First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First Quarter Adjusted EBITDA profitability of $6.8 million versus prior period loss of $37.5 million Improves 2024 guidance to Insurance Revenue of $1.30 billion - $1.35 billion and Adjusted EBITDA profitability of $10 million - $30...Read more
WOONSOCKET, R.I., May 7, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Bank of America 2024 Healthcare Conference on May 14, 2024, at approximately 7:20 a.m. pacific time. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at...Read more
For the quarter ended March 31, 2024: Total Revenue of $2.1 billion, a 46% increase YoY Medical Loss Ratio of 74.2%, a 210 bps improvement YoY SG&A Expense Ratio of 18.4%, an 870 bps improvement YoY Net Income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share, a $217.1 million improvement YoY Adjusted EBITDA of $219.3 million, a $168.2 million improvement YoY NEW YORK / May 07, 2024 / Business...Read more
LOUISVILLE, Ky. / May 02, 2024 / Business Wire / Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com. The company...Read more
Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectively Medicare Advantage membership grows 50.5% year-over-year to approximately 165,100 members Increases membership and revenue outlook following strong first-quarter enrollment results, narrows year-end adjusted EBITDA guidance range ORANGE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Alignment...Read more
ST. LOUIS and NASHVILLE, Tenn., May 2, 2024 /PRNewswire/ -- Wellcare, the Medicare business of Centene Corporation (NYSE: CNC), and Wellvana, a value-based care physician enablement company, today announced a multi-year partnership that seeks to expand affordable, patient-centered primary healthcare to thousands of Wellcare Medicare Advantage members in Georgia, Tennessee and Texas. The partnership will support independent primary...Read more
Total revenues for the first quarter 2024 were $57.3 billion Shareholders' net loss for the first quarter 2024 was $0.3 billion, or $0.97 per share Adjusted income from operations1 for the first quarter 2024 was $1.9 billion, or $6.47 per share 2024 outlook2 for adjusted income from operations1,2 increased to at least $28.40 per share BLOOMFIELD, Conn., May 2, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:...Read more
First Quarter Highlights Total revenues increased to $88.4 billion, up 3.7% compared to prior year GAAP diluted EPS of $0.88 and Adjusted EPS of $1.31 Generated cash flow from operations of $4.9 billion 2024 Full-Year Guidance Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06 Revised Adjusted EPS guidance to at least $7.00 from at least $8.30 Revised cash flow from operations guidance to at least $10.5...Read more
ORANGE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at the following conferences: BofA Securities 2024 Health Care Conference on Thursday, May 16, at 8:40 a.m. PDT Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, at 10:40 a.m. CDT A webcast and replay of the...Read more
Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26Increases 2024 Full Year Guidance 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023. Increases 2024 full year adjusted diluted EPS guidance by $0.10 to greater than $6.80. Premium and service revenues of $36.3 billion in the first quarter of 2024. Increases 2024 full year premium and service revenue guidance by $1.0 billion. Membership increase...Read more
Reaffirms Full Year 2024 Guidance LONG BEACH, Calif. / Apr 24, 2024 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. Financial results are summarized below: Three months ended March...Read more
TAMPA, Fla., April 24, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced the strategic hiring of two industry-renowned salespeople, significantly strengthening its sales force with a focus on...Read more
Reports 1Q24 earnings per share (EPS) of $6.11 on a GAAP basis, Adjusted EPS of $7.23 Revises FY 2024 EPS guidance to 'approximately $13.93' (previously 'approximately $14.87') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 50,000 to now anticipate annual growth of...Read more
New solutions elevate and expedite patient care with upstream moments of influence BOSTON and LOUISVILLE, Ky., April 23, 2024 /PRNewswire/ -- Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere's prior authorization platform for diagnostic imaging and sleep services. "Expanding our partnership...Read more
FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024. With a wealth of experience and a proven...Read more
1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 1Q 2024 diluted EPS1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS2 of $10.64, up 12.5% FY 2024 diluted EPS and adjusted diluted EPS guidance raised to greater than $34.05 and $37.20, respectively Launching strategic partnership to advance primary care and physician enablement INDIANAPOLIS / Apr 18, 2024 / Business Wire / Elevance Health, Inc. (NYSE: ELV)...Read more
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE